Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yupingfeng oral solution (玉屏风口服液) is an approved traditional Chinese herbal oral liquid formulation developed and manufactured by Zhejiang Jinliyuan Pharmaceutical. Based on the classic Traditional Chinese Medicine (TCM) formula Yupingfeng San (Yu Ping Feng San), it is composed of three herbal ingredients: Astragali Radix (Huangqi), Atractylodis Macrocephalae Rhizoma (Baizhu), and Saposhnikoviae Radix (Fangfeng), typically in a 3:1:1 weight ratio. Listed in the Chinese Pharmacopoeia, the formulation is primarily used for its immunomodulatory, anti-inflammatory, and antioxidant effects. It is indicated for the treatment of recurrent respiratory tract infections, allergic rhinitis, chronic bronchitis, and related immune-deficiency states. Consistent with its multi-component TCM nature, it lacks a single discrete biological target, instead exerting therapeutic effects through a network of bioactive constituents including flavonoids, saponins, and polysaccharides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yupingfeng oral solution.